Antisense TR3 orphan receptor can increase prostate cancer cell viability with etoposide treatment (Q74493389)
Jump to navigation
Jump to search
scientific article published on 01 May 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Antisense TR3 orphan receptor can increase prostate cancer cell viability with etoposide treatment |
scientific article published on 01 May 1998 |
Statements
Antisense TR3 orphan receptor can increase prostate cancer cell viability with etoposide treatment (English)
Uemura H